Selected research
Market Analysis & Forecast
Global Oligonucleotide Array Market Analysis and Forecast 2026-2032
Market perspective
The global Oligonucleotide Array market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Oligonucleotide Array's global sales reached XX (k units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Illumnia as the global sales leader, a title it has maintained for several consecutive years. Notably, Illumnia's performance in primary markets is also remarkable. In the Chinese market, sales were XX (k units), a change of XX% from the previous year. In Europe, sales were XX (k units), showing a year-on-year of XX%. In the US, sales were XX (k units), a year-on-year change of XX%.
The major global manufacturers in the Oligonucleotide Array market include Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, Sengenics, Arrayit, Applied Microarrays, Biometrix Technology and Savyon Diagnostics, etc. In 2025, the top three vendors accounted for approximately % of the revenue.
Read the full market overview
In terms of production side, this report researches the Oligonucleotide Array production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.
In terms of consumption side, this report focuses on the sales of Oligonucleotide Array by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.
This report presents an overview of global market for Oligonucleotide Array, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Oligonucleotide Array, also provides the consumption of main regions and countries. Of the upcoming market potential for Oligonucleotide Array, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oligonucleotide Array sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oligonucleotide Array market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oligonucleotide Array sales, projected growth trends, production technology, application and end-user industry.
Oligonucleotide Array Segment by Company
Illumnia
Affymetrix
Agilent Technologies
Roche NimbleGen
Sengenics
Arrayit
Applied Microarrays
Biometrix Technology
Savyon Diagnostics
Scienion AG
WaferGen
Oligonucleotide Array Segment by Type
Long Oligonucleotide Chip
Short Oligonucleotide Chip
Oligonucleotide Array Segment by Application
Gene Expression
Genotyping
Others
Oligonucleotide Array Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotide Array market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotide Array and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotide Array.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Oligonucleotide Array production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Oligonucleotide Array in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Oligonucleotide Array manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotide Array sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Long Oligonucleotide Chip
- Short Oligonucleotide Chip
Applications
- Gene Expression
- Genotyping
- Others
Companies covered
- Illumnia
- Affymetrix
- Agilent Technologies
- Roche NimbleGen
- Sengenics
- Arrayit
- Applied Microarrays
- Biometrix Technology
- Savyon Diagnostics
- Scienion AG
- WaferGen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Oligonucleotide Array Market by Type
- 1.2.1 Global Oligonucleotide Array Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Long Oligonucleotide Chip
- 1.2.3 Short Oligonucleotide Chip
- 1.3 Oligonucleotide Array Market by Application
- 1.3.1 Global Oligonucleotide Array Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Gene Expression
- 1.3.3 Genotyping
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Oligonucleotide Array Market Dynamics
- 2.1 Oligonucleotide Array Industry Trends
- 2.2 Oligonucleotide Array Industry Drivers
- 2.3 Oligonucleotide Array Industry Opportunities and Challenges
- 2.4 Oligonucleotide Array Industry Restraints
3 Global Oligonucleotide Array Production Overview
- 3.1 Global Oligonucleotide Array Production Capacity (2021-2032)
- 3.2 Global Oligonucleotide Array Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Oligonucleotide Array Production by Region
- 3.3.1 Global Oligonucleotide Array Production by Region (2021-2026)
- 3.3.2 Global Oligonucleotide Array Production by Region (2027-2032)
- 3.3.3 Global Oligonucleotide Array Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
- 3.8 South Korea
4 Global Market Growth Prospects
- 4.1 Global Oligonucleotide Array Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Oligonucleotide Array Revenue by Region
- 4.2.1 Global Oligonucleotide Array Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Oligonucleotide Array Revenue by Region (2021-2026)
- 4.2.3 Global Oligonucleotide Array Revenue by Region (2027-2032)
- 4.2.4 Global Oligonucleotide Array Revenue Market Share by Region (2021-2032)
- 4.3 Global Oligonucleotide Array Sales Estimates and Forecasts 2021-2032
- 4.4 Global Oligonucleotide Array Sales by Region
- 4.4.1 Global Oligonucleotide Array Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Oligonucleotide Array Sales by Region (2021-2026)
- 4.4.3 Global Oligonucleotide Array Sales by Region (2027-2032)
- 4.4.4 Global Oligonucleotide Array Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Oligonucleotide Array Revenue by Manufacturers
- 5.1.1 Global Oligonucleotide Array Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Oligonucleotide Array Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Oligonucleotide Array Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Oligonucleotide Array Sales by Manufacturers
- 5.2.1 Global Oligonucleotide Array Sales by Manufacturers (2021-2026)
- 5.2.2 Global Oligonucleotide Array Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Oligonucleotide Array Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Oligonucleotide Array Sales Price by Manufacturers (2021-2026)
- 5.4 Global Oligonucleotide Array Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Oligonucleotide Array Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Oligonucleotide Array Manufacturers, Product Type & Application
- 5.7 Global Oligonucleotide Array Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Oligonucleotide Array Market CR5 and HHI
- 5.8.2 2025 Oligonucleotide Array Tier 1, Tier 2, and Tier 3
6 Oligonucleotide Array Market by Type
- 6.1 Global Oligonucleotide Array Revenue by Type
- 6.1.1 Global Oligonucleotide Array Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Oligonucleotide Array Revenue Market Share by Type (2021-2032)
- 6.2 Global Oligonucleotide Array Sales by Type
- 6.2.1 Global Oligonucleotide Array Sales by Type (2021-2032) & (k units)
- 6.2.2 Global Oligonucleotide Array Sales Market Share by Type (2021-2032)
- 6.3 Global Oligonucleotide Array Price by Type
7 Oligonucleotide Array Market by Application
- 7.1 Global Oligonucleotide Array Revenue by Application
- 7.1.1 Global Oligonucleotide Array Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Oligonucleotide Array Revenue Market Share by Application (2021-2032)
- 7.2 Global Oligonucleotide Array Sales by Application
- 7.2.1 Global Oligonucleotide Array Sales by Application (2021-2032) & (k units)
- 7.2.2 Global Oligonucleotide Array Sales Market Share by Application (2021-2032)
- 7.3 Global Oligonucleotide Array Price by Application
8 Company Profiles
- 8.1 Illumnia
- 8.1.1 Illumnia Company Information
- 8.1.2 Illumnia Business Overview
- 8.1.3 Illumnia Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Illumnia Oligonucleotide Array Product Portfolio
- 8.1.5 Illumnia Recent Developments
- 8.2 Affymetrix
- 8.2.1 Affymetrix Company Information
- 8.2.2 Affymetrix Business Overview
- 8.2.3 Affymetrix Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Affymetrix Oligonucleotide Array Product Portfolio
- 8.2.5 Affymetrix Recent Developments
- 8.3 Agilent Technologies
- 8.3.1 Agilent Technologies Company Information
- 8.3.2 Agilent Technologies Business Overview
- 8.3.3 Agilent Technologies Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Agilent Technologies Oligonucleotide Array Product Portfolio
- 8.3.5 Agilent Technologies Recent Developments
- 8.4 Roche NimbleGen
- 8.4.1 Roche NimbleGen Company Information
- 8.4.2 Roche NimbleGen Business Overview
- 8.4.3 Roche NimbleGen Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Roche NimbleGen Oligonucleotide Array Product Portfolio
- 8.4.5 Roche NimbleGen Recent Developments
- 8.5 Sengenics
- 8.5.1 Sengenics Company Information
- 8.5.2 Sengenics Business Overview
- 8.5.3 Sengenics Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 Sengenics Oligonucleotide Array Product Portfolio
- 8.5.5 Sengenics Recent Developments
- 8.6 Arrayit
- 8.6.1 Arrayit Company Information
- 8.6.2 Arrayit Business Overview
- 8.6.3 Arrayit Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Arrayit Oligonucleotide Array Product Portfolio
- 8.6.5 Arrayit Recent Developments
- 8.7 Applied Microarrays
- 8.7.1 Applied Microarrays Company Information
- 8.7.2 Applied Microarrays Business Overview
- 8.7.3 Applied Microarrays Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.7.4 Applied Microarrays Oligonucleotide Array Product Portfolio
- 8.7.5 Applied Microarrays Recent Developments
- 8.8 Biometrix Technology
- 8.8.1 Biometrix Technology Company Information
- 8.8.2 Biometrix Technology Business Overview
- 8.8.3 Biometrix Technology Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.8.4 Biometrix Technology Oligonucleotide Array Product Portfolio
- 8.8.5 Biometrix Technology Recent Developments
- 8.9 Savyon Diagnostics
- 8.9.1 Savyon Diagnostics Company Information
- 8.9.2 Savyon Diagnostics Business Overview
- 8.9.3 Savyon Diagnostics Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.9.4 Savyon Diagnostics Oligonucleotide Array Product Portfolio
- 8.9.5 Savyon Diagnostics Recent Developments
- 8.10 Scienion AG
- 8.10.1 Scienion AG Company Information
- 8.10.2 Scienion AG Business Overview
- 8.10.3 Scienion AG Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.10.4 Scienion AG Oligonucleotide Array Product Portfolio
- 8.10.5 Scienion AG Recent Developments
- 8.11 WaferGen
- 8.11.1 WaferGen Company Information
- 8.11.2 WaferGen Business Overview
- 8.11.3 WaferGen Oligonucleotide Array Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.11.4 WaferGen Oligonucleotide Array Product Portfolio
- 8.11.5 WaferGen Recent Developments
9 North America
- 9.1 North America Oligonucleotide Array Market Size by Type
- 9.1.1 North America Oligonucleotide Array Revenue by Type (2021-2032)
- 9.1.2 North America Oligonucleotide Array Sales by Type (2021-2032)
- 9.1.3 North America Oligonucleotide Array Price by Type (2021-2032)
- 9.2 North America Oligonucleotide Array Market Size by Application
- 9.2.1 North America Oligonucleotide Array Revenue by Application (2021-2032)
- 9.2.2 North America Oligonucleotide Array Sales by Application (2021-2032)
- 9.2.3 North America Oligonucleotide Array Price by Application (2021-2032)
- 9.3 North America Oligonucleotide Array Market Size by Country
- 9.3.1 North America Oligonucleotide Array Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Oligonucleotide Array Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Oligonucleotide Array Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe Oligonucleotide Array Market Size by Type
- 10.1.1 Europe Oligonucleotide Array Revenue by Type (2021-2032)
- 10.1.2 Europe Oligonucleotide Array Sales by Type (2021-2032)
- 10.1.3 Europe Oligonucleotide Array Price by Type (2021-2032)
- 10.2 Europe Oligonucleotide Array Market Size by Application
- 10.2.1 Europe Oligonucleotide Array Revenue by Application (2021-2032)
- 10.2.2 Europe Oligonucleotide Array Sales by Application (2021-2032)
- 10.2.3 Europe Oligonucleotide Array Price by Application (2021-2032)
- 10.3 Europe Oligonucleotide Array Market Size by Country
- 10.3.1 Europe Oligonucleotide Array Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Oligonucleotide Array Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Oligonucleotide Array Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China Oligonucleotide Array Market Size by Type
- 11.1.1 China Oligonucleotide Array Revenue by Type (2021-2032)
- 11.1.2 China Oligonucleotide Array Sales by Type (2021-2032)
- 11.1.3 China Oligonucleotide Array Price by Type (2021-2032)
- 11.2 China Oligonucleotide Array Market Size by Application
- 11.2.1 China Oligonucleotide Array Revenue by Application (2021-2032)
- 11.2.2 China Oligonucleotide Array Sales by Application (2021-2032)
- 11.2.3 China Oligonucleotide Array Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Oligonucleotide Array Market Size by Type
- 12.1.1 Asia Oligonucleotide Array Revenue by Type (2021-2032)
- 12.1.2 Asia Oligonucleotide Array Sales by Type (2021-2032)
- 12.1.3 Asia Oligonucleotide Array Price by Type (2021-2032)
- 12.2 Asia Oligonucleotide Array Market Size by Application
- 12.2.1 Asia Oligonucleotide Array Revenue by Application (2021-2032)
- 12.2.2 Asia Oligonucleotide Array Sales by Application (2021-2032)
- 12.2.3 Asia Oligonucleotide Array Price by Application (2021-2032)
- 12.3 Asia Oligonucleotide Array Market Size by Country
- 12.3.1 Asia Oligonucleotide Array Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Oligonucleotide Array Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Oligonucleotide Array Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Oligonucleotide Array Market Size by Type
- 13.1.1 SAMEA Oligonucleotide Array Revenue by Type (2021-2032)
- 13.1.2 SAMEA Oligonucleotide Array Sales by Type (2021-2032)
- 13.1.3 SAMEA Oligonucleotide Array Price by Type (2021-2032)
- 13.2 SAMEA Oligonucleotide Array Market Size by Application
- 13.2.1 SAMEA Oligonucleotide Array Revenue by Application (2021-2032)
- 13.2.2 SAMEA Oligonucleotide Array Sales by Application (2021-2032)
- 13.2.3 SAMEA Oligonucleotide Array Price by Application (2021-2032)
- 13.3 SAMEA Oligonucleotide Array Market Size by Country
- 13.3.1 SAMEA Oligonucleotide Array Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Oligonucleotide Array Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Oligonucleotide Array Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Oligonucleotide Array Value Chain Analysis
- 14.1.1 Oligonucleotide Array Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Oligonucleotide Array Production Mode & Process
- 14.2 Oligonucleotide Array Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Oligonucleotide Array Distributors
- 14.2.3 Oligonucleotide Array Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst